Thu, Nov 27, 2014, 9:45 AM EST - U.S. Markets closed for Thanksgiving Day


% | $
Quotes you view appear here for quick access.

ImmunoCellular Therapeutics, Ltd. Message Board

  • chessnotcheckersed chessnotcheckersed Nov 8, 2012 9:24 AM Flag

    Don't you people realize you won't have any interim results for almost another year...

    If you don't know this call the company. The only thing you will have is the data monitoring board giving them the green light some time in the first quarter of next year. Be nice to an insider purchase. Dr. Yu has so little shares it speaks volumes.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I can't believe no one else has said this; When you say 12 months, do you mean 4 months? What you are saying is just a flat out lie. It isn't remotely what the company has said. Also, Dr. Yu has so many options, why would he need to purchase shares? If you want to talk about insider buying or selling, to me what matters is whether Manish Singh, who owns over 900,000 shares, has sold any of his shares. According the quarterly report put forth on Friday, he hasn't. This is information which can be confirmed on Wednesday at the investor meeting. Also, just because you don't have interim analysis does not mean that you don't have data. You know when the patients enrolled in the trial. It's not like you can't anticipate when 32 events are likely to occur if the vaccine doesn't work. By not getting interim analysis, you are in fact receiving confirmation that the vaccine is working.

    • I agree that one must be cognizant of the data vacuum. And also agree, that insider buying is what you want to see when the stock of a company with excellent prospects has come in sharply. On the other hand, there is a price and valuation at which your may be getting a discount on the probability that when the data does come out, we see great data again. At $3.75 per share, perhaps the stock was ahead of itself. At $1.75 - $1.90, and after raising capital, one can argue that the valuation relative to comparables and no need to raise money for at least a year, suggests that you are getting the optionality at a nice discount

    • Yep, nadda happening for awhile. I like it, no noise, no hype now.

0.61080.0000(0.00%)Nov 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.